ENLV · Pre-market
$0.65
-1.41% today·exchange $0.65
Enlivex Ltd. is an Israel-based clinical-stage macrophage reprogramming immunotherapy company focused on developing innovative cell therapies for sepsis, osteoarthritis, and psoriatic arthritis.
Enlivex Ltd. (ENLV) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Zacks · 23d ago
Enlivex Shares Plunge After $400 Million Private Placement Deal
MT Newswires · 58d ago
Top Midday Decliners
MT Newswires · 58d ago
Enlivex Ltd. (ENLV) Upgraded to Buy: Here's Why
Zacks · 73d ago
Enlivex Ltd. (ENLV) Loses 31.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks · 73d ago
Enlivex's Allocetra Receives FDA RMAT Designation for Knee Osteoarthritis
MT Newswires · 73d ago
Headlines from Yahoo Finance. Not investment advice.
